Is Crispr Therapeutics Stock A Bad News Buy?

newsfeedback@fool.com (George Budwell), The Motley Fool
Thu, 05/31/2018 - 4:55am

Shares of the gene-editing company Crispr Therapeutics (NASDAQ: CRSP) fell by more than 14% in pre-market trading today. The culprit?Crispr and its development partner Vertex Pharmaceuticals (NASDAQ: VRTX) announced after the bell Wednesday that the Food and Drug Administration (FDA) has placed a clinical hold on the Investigational New Drug (IND) application for their sickle cell disease product candidate, CTX-001.

Topics: crispr therapeutics nasdaq crsp vertex pharmaceuticals nasdaq vrtx food drug administration fda investigational new drug ind united states cas9 crispr-associated dna ctx-001 crispr gene-editing company product candidate hold

Place your ad here
Loading...

BING NEWS:

CRISPR Therapeutics: Strong Balance Sheet Supports Ambitious Plans Amid Slow Growth
CRISPR Therapeutics' Q3 saw reduced expenses and slow Casgevy launch, resulting in a revenue miss. Read why I am neutral on CRSP stock.
12/2/2024 - 6:11 pm | View Link
Stock Slump or Stepping Stone? What’s Next for Applied Therapeutics (APLT) After FDA’s Latest Blow
This sharp decline in the company’s stock raises several questions about its future prospects, especially given the positive momentum it had been building throughout the year. Let’s delve into what ...
11/29/2024 - 1:13 am | View Link
Crispr Therapeutics AG: Buy Rating Affirmed Amid Pipeline Progress and Strategic Collaborations
the anticipation of future revenue recognition and continued pipeline developments supports the positive outlook for Crispr Therapeutics’ stock. According to TipRanks, Foroohar is an analyst ...
11/6/2024 - 12:07 pm | View Link
CRISPR Therapeutics (NASDAQ:CRSP) Stock Quotes, Forecast and News Summary
Cathie Wood Sees Tesla As 'Largest AI Project On Earth' — Here's Why She's Not Worried About Tech Investments Cathie Wood, founder and CEO of ARK Investment Management LLC, defended the future ...
10/31/2024 - 1:20 pm | View Link
CRISPR Therapeutics AG (CRSP)
Over the past several weeks, Wood has added to one of her key positions, a stock that's lost about 20% this year. On Nov. 21, shares of CRISPR Therapeutics (NASDAQ: CRSP) were down 47% from a peak ...
06/10/2017 - 1:41 am | View Link
More

More Movie News

More Business News

These spiders listen for prey before hurling webs like slingshots
Ars Technica, Wednesday - 12/04/2024 - 06:00 PM
A tethered mosquito approaches the web in the path of release of the cone, and triggers web release response. Credit: S. I. Han and T. A. Blackledge, 2024. A tethered mosquito approaches the web in the path of release of the cone, and triggers web release response. Credit: S. I.
More | Talk | Read It Later | Share
Dog domestication happened many times, but most didn’t pan out
Ars Technica, Wednesday - 12/04/2024 - 05:16 PM
Between 8,000 and 12,000 years ago, people in Alaska kept reinventing dogs with mixed results. The dogs that share our homes today are the descendants of a single group of wolves that lived in Siberia about 23,000 years ago. But for thousands of years after that split, the line between wolf and dog wasn’t quite clear-cut.
More | Talk | Read It Later | Share
UnitedHealthcare CEO kept a low public profile. Then he was shot to death in New York
Chicago Tribune, Wednesday - 12/04/2024 - 04:26 PM
NEW YORK — Brian Thompson led one of the biggest health insurers in the U. S. but was unknown to millions of the people his decisions affected. Then Wednesday’s fatal shooting of the UnitedHealthcare CEO in a targeted killing on a midtown Manhattan sidewalk thrust the executive and his business into the national spotlight. Thompson, who was 50, ran the insurance arm of the giant UnitedHealth Group Inc.
More | Talk | Read It Later | Share
Suburban roofing contractor cited again for alleged safety hazards: ‘A callous invitation to tragedy’
Chicago Tribune, Wednesday - 12/04/2024 - 04:09 PM
A suburban roofing company that has repeatedly faced the ire of federal safety regulators has been hit with more citations for putting workers at risk of falls, the Occupational Safety and Health Administration said Wednesday. OSHA said it was the eighth time it has cited Lake Zurich-based Fino Exterior Inc. since 2020.
More | Talk | Read It Later | Share
Ranking report: Naperville nursing homes among the top in the country
Chicago Tribune, Wednesday - 12/04/2024 - 03:55 PM
The Springs at Monarch Landing in Naperville is among the best nursing homes in the country, according to a recent report from Newsweek. In September, Newsweek released its list for America’s Best Nursing Homes of 2025. The ranking recognizes 1,050 of the country’s top nursing homes. Honorees include The Springs at Monarch Landing, which came in as the No.
More | Talk | Read It Later | Share
OpenAI teases 12 days of mystery product launches starting tomorrow
Ars Technica, Wednesday - 12/04/2024 - 03:15 PM
On Wednesday, OpenAI CEO Sam Altman announced a "12 days of OpenAI" period starting December 5, which will unveil new AI features and products for 12 consecutive weekdays. Altman did not specify the exact features or products OpenAI plans to unveil, but a report from The Verge about this "12 days of shipmas" event suggests the products may include a public release of the company's text-to-video model Sora and a new "reasoning" AI model similar to o1-preview.
More | Talk | Read It Later | Share

Is Crispr Therapeutics Stock A Bad News Buy?

Welcome to Wopular

MoviesWithButter : Our Sister Site

More Business News